Brief: Amniotics Gets GMP Certification Renewed
23/11/2023 11:41
Nov 23 (Reuters) - Amniotics AB (publ) AMNI.ST :
* GETS RENEWED CERTIFICATE OF GMP COMPLIANCE OF A
MANUFACTURER AND
PERMIT BY SWEDISH MEDICAL PRODUCTS AGENCY
* PERMIT IS VALID UNTIL 2028-08-24
* CERTIFICATE TO MANUFACTURE PRODUCTS BASED ON MESENCHYMAL
STEM
CELLS ISOLATED FROM AMNIOTIC FLUID, ASEPTIC RECONSTITUTION OF
CELL THERAPY PRODUCTS
Source text for Eikon: ID:nMFN6PHkpQ
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan